Biomechanics and mechanobiology of the bone matrix

C Ma, T Du, X Niu, Y Fan - Bone research, 2022 - nature.com
The bone matrix plays an indispensable role in the human body, and its unique
biomechanical and mechanobiological properties have received much attention. The bone …

Wnt signaling in the development of bone metastasis

N Ben-Ghedalia-Peled, R Vago - Cells, 2022 - mdpi.com
Wnt signaling occurs through evolutionarily conserved pathways that affect cellular
proliferation and fate decisions during development and tissue maintenance. Alterations in …

Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity

H Zhou, W Zhang, H Li, F Xu, E Yinwang, Y Xue… - Science …, 2024 - science.org
Bone is one of the most common sites of tumor metastases. During the last step of bone
metastasis, cancer cells colonize and disrupt the bone matrix, which is maintained mainly by …

[HTML][HTML] Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling

X Sun, K Li, M Hase, R Zha, Y Feng, BY Li… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Bone is a frequent site of metastases from breast cancer, but existing
therapeutic options are not satisfactory. Although osteoblasts have active roles in cancer …

[HTML][HTML] Generation of the tumor-suppressive secretome from tumor cells

S Liu, X Sun, K Li, R Zha, Y Feng, T Sano, C Dong… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: The progression of cancer cells depends on the soil and building an inhibitory
soil might be a therapeutic option. We previously created tumor-suppressive secretomes by …

[HTML][HTML] Counterintuitive production of tumor-suppressive secretomes from Oct4-and c-Myc-overexpressing tumor cells and MSCs

K Li, X Sun, R Zha, S Liu, Y Feng, T Sano, UK Aryal… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Advanced breast cancer frequently metastasizes to bone, but inhibiting tumor
progression in chemotherapy may occasionally enhance tumorigenesis. Here, we employed …

Prostate cancer and bone: clinical presentation and molecular mechanisms

KV Wells, ML Krackeler, MK Jathal… - Endocrine-related …, 2023 - erc.bioscientifica.com
Prostate cancer (PCa) is an increasingly prevalent health problem in the developed world.
Effective treatment options exist for localized PCa, but metastatic PCa has fewer treatment …

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

K Li, Q Huo, NH Dimmitt, G Qu, J Bao, PH Pandya… - Elife, 2023 - elifesciences.org
Osteosarcoma (OS) is the common primary bone cancer that affects mostly children and
young adults. To augment the standard-of-care chemotherapy, we examined the possibility …

[HTML][HTML] Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis

K Li, X Sun, K Minami, K Tamari, K Ogawa, H Li… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: During a developmental process, embryos employ varying tactics to remove
unwanted cells. Using a procedure analogous to some of the embryonic cells, we generated …

[HTML][HTML] Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes

K Li, X Sun, H Li, H Ma, M Zhou, K Minami, K Tamari… - Genes & …, 2023 - Elsevier
Cancer cells tend to develop resistance to chemotherapy and enhance aggressiveness. A
counterintuitive approach is to tame aggressiveness by an agent that acts opposite to …